SUBSCRIBE
SUBSCRIBE
News   Drug Development

Drug Sorafenib Improves Kidney Cancer Outcomes, Addenbrooke’s Hospital And University of Cambridge Study

October 10, 2008 | 
1 min read

MedPage Today -- CAMBRIDGE, England, Oct. 7 -- For advanced renal cell carcinoma, sorafenib (Nexavar) improves outcomes in both younger and older patients, according to a post-hoc analysis.

Clinical research Postmarket research Europe
MORE ON THIS TOPIC
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis
3d rendering medical heart in yellow background
Cardiovascular disease
AstraZeneca’s Baxdrostat Pushes Blood Pressure Lower in Phase III Trial
July 14, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Pictured: Takeda sign at its office in Massachusetts
Neuroscience
Takeda Establishes Lead in Narcolepsy Race With Back-to-Back Phase III Wins
July 14, 2025
 · 
2 min read
 · 
Tristan Manalac
vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake
Depression
After Three Strikes, Relmada Abandons Depression Drug Esmethadone 
July 14, 2025
 · 
2 min read
 · 
Tristan Manalac